H. Jürgens

669 total citations
21 papers, 388 citations indexed

About

H. Jürgens is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, H. Jürgens has authored 21 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in H. Jürgens's work include Testicular diseases and treatments (12 papers), Neuroblastoma Research and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). H. Jürgens is often cited by papers focused on Testicular diseases and treatments (12 papers), Neuroblastoma Research and Treatments (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). H. Jürgens collaborates with scholars based in Germany, Austria and United States. H. Jürgens's co-authors include Gabriele Calaminus, U. Göbel, M. Bamberg, D. Harms, H. Spaar, O. D. Wiestler, D. Harms, Dominik T. Schneider, K.-L. Waag and Luca Cordero di Montezemolo and has published in prestigious journals such as Journal of Clinical Oncology, Critical Reviews in Oncology/Hematology and Neuropediatrics.

In The Last Decade

H. Jürgens

19 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Jürgens Germany 8 277 180 129 118 55 21 388
Larry E. Kun United States 9 88 0.3× 186 1.0× 165 1.3× 153 1.3× 21 0.4× 9 367
R. N. HITCHINS United Kingdom 7 151 0.5× 174 1.0× 298 2.3× 72 0.6× 25 0.5× 11 438
Steven Halpern United States 7 95 0.3× 151 0.8× 98 0.8× 124 1.1× 88 1.6× 10 373
Antônio Gonçalves de Oliveira-Filho Brazil 11 379 1.4× 85 0.5× 57 0.4× 104 0.9× 13 0.2× 21 518
A. Zabel-du Bois Germany 16 188 0.7× 136 0.8× 156 1.2× 394 3.3× 20 0.4× 21 749
J P Constans France 8 367 1.3× 105 0.6× 163 1.3× 54 0.5× 21 0.4× 16 531
Christoph M. Woernle Switzerland 14 231 0.8× 141 0.8× 90 0.7× 208 1.8× 21 0.4× 29 603
Calogero Virgone Italy 13 391 1.4× 46 0.3× 68 0.5× 87 0.7× 26 0.5× 50 531
Yeon Lim Suh South Korea 11 125 0.5× 80 0.4× 66 0.5× 96 0.8× 6 0.1× 37 321
Trevor G. DeSouza United States 6 92 0.3× 118 0.7× 173 1.3× 61 0.5× 9 0.2× 6 339

Countries citing papers authored by H. Jürgens

Since Specialization
Citations

This map shows the geographic impact of H. Jürgens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Jürgens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Jürgens more than expected).

Fields of papers citing papers by H. Jürgens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Jürgens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Jürgens. The network helps show where H. Jürgens may publish in the future.

Co-authorship network of co-authors of H. Jürgens

This figure shows the co-authorship network connecting the top 25 collaborators of H. Jürgens. A scholar is included among the top collaborators of H. Jürgens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Jürgens. H. Jürgens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spaar, H., J. Michaelis, D Niethammer, et al.. (2008). Bedeutung der präoperativen Chemotherapie und der Radiotherapie bei 373 Kindern mit Wilms-Tumor*. DMW - Deutsche Medizinische Wochenschrift. 115(7). 248–253.
2.
Calaminus, Gabriele, M. Bamberg, D. Harms, et al.. (2005). AFP/β-HCG Secreting CNS Germ Cell Tumors: Long-Term Outcome with Respect to Initial Symptoms and Primary Tumor Resection. Results of the Cooperative Trial MAKEI 89. Neuropediatrics. 36(2). 71–77. 71 indexed citations
3.
Göbel, U., Dominik T. Schneider, Gabriele Calaminus, et al.. (2001). Multimodal Treatment of Malignant Sacrococcygeal Germ Cell Tumors: A Prospective Analysis of 66 Patients of the German Cooperative Protocols MAKEI 83/86 and 89. Journal of Clinical Oncology. 19(7). 1943–1950. 64 indexed citations
4.
Thelen, Marc, et al.. (1997). Rezidiv eines Neuroblastoms Stadium IV. Nuklearmedizin - NuclearMedicine. 36(1). 32–35. 1 indexed citations
5.
Pötter, Richard, Uwe Haverkamp, R. Hawliczek, et al.. (1995). Brachytherapy in the Combined Modality Treatment of Pediatric Malignancies. Principles and Preliminary Experience with Treatment of Soft Tissue Sarcoma (Recurrence) and Ewing's Sarcoma. Klinische Pädiatrie. 207(4). 164–173. 22 indexed citations
6.
Calaminus, Gabriele, M. Bamberg, M.C. Baranzelli, et al.. (1994). Intracranial Germ Cell Tumors: A Comprehensive Update of the European Data. Neuropediatrics. 25(1). 26–32. 114 indexed citations
8.
Göbel, U., Gabriele Calaminus, C. Teske, et al.. (1993). BEP/VIP bei Kindern und Jugendlichen mit malignen nichttestikulären Keimzelltumoren. Klinische Pädiatrie. 205(4). 231–240. 24 indexed citations
9.
Göbel, U., M. Bamberg, J. Engert, et al.. (1991). Die Behandlung nichttestikulärer Keimzelltumoren bei Kindern und Jugendlichen mit BEP und VIP: Erste Ergebnisse der Therapiestudie MAKEI 89. Klinische Pädiatrie. 203(4). 236–245. 3 indexed citations
10.
Kościelniak, Ewa, J. Treuner, H. Jürgens, et al.. (1991). Die Behandlung der Weichteilsarkome im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie CWS-81*. Klinische Pädiatrie. 203(4). 211–219. 5 indexed citations
11.
Calaminus, Gabriele, J.P.M. Bökkerink, H. Gadner, et al.. (1991). Die prognostische Bedeutung des Serum α1-Fetoproteins (AFP) bei Kindern und Jugendlichen mit malignen extrakranialen nichttestikulären Keimzelltumoren. Klinische Pädiatrie. 203(4). 246–250. 14 indexed citations
12.
Haas, Rainer, Gabriele Calaminus, M. Bamberg, et al.. (1990). Treatment of germ cell tumors in children: Results of European trials for testicular and non-testicular primary sites. Critical Reviews in Oncology/Hematology. 10(2). 89–98. 12 indexed citations
13.
Göbel, U., M. Bamberg, Rainer Haas, et al.. (1989). Nichttestikuläre Keimzelltumoren: Analyse der Therapiestudie MAKEI 83/86 und Protokolländerungen für die Nachfolgestudie. Klinische Pädiatrie. 201(4). 247–260. 4 indexed citations
14.
Creutzig, U., G. Henze, H. Jürgens, et al.. (1987). Hochdosiertes ARA-C in Kombination mit Mitoxantron bei der Therapie der AML im Kindesalter. Oncology Research and Treatment. 10(1). 24–27. 5 indexed citations
15.
Göbel, U., et al.. (1987). [Cellular immunity using skin tests in children with malignant diseases at the time of diagnosis and after therapy].. PubMed. 10(3 Suppl). 4–7.
16.
Distler, W., et al.. (1986). Pubertätsentwicklung und Ovarialfunktion nach Zytostatikatherapie im Kindesalter*. Geburtshilfe und Frauenheilkunde. 46(4). 237–241. 3 indexed citations
17.
Janßen, G., et al.. (1986). Hepatitis-B-Infektionen bei zytostatisch behandelten Kindern*. Klinische Pädiatrie. 198(3). 285–290. 1 indexed citations
18.
Göbel, U., P. Gutjahr, H. Jürgens, et al.. (1986). Die kooperative Therapiestudie für nichttestikuläre Keimzelltumoren MAKEI 83 der GPO: Analyse nach 3 Jahren*/**. Klinische Pädiatrie. 198(3). 237–244. 1 indexed citations
19.
Göbel, U., W. Brandeis, H. Gadner, et al.. (1985). Preliminary Results of the GPO-Trial for Treatment of Non-Testicular Germ-Cell Tumors in Children and Adolescents. Oncology Research and Treatment. 8(3). 178–180. 2 indexed citations
20.
Göbel, U., et al.. (1978). The reproductiveness of bleeding time tests.. PubMed. 30(17). 1391–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026